THE TREATMENT OF FAR-ADVANCED MALIGNANT DISEASE

Malignant Melanoma: Staging and Treatment of Localized and Advanced Disease.

For most solid tumors, including melanoma, the most powerful predictor of recurrence and survival is the presence or absence of regional lymph node metastases. For patients with melanoma and stage III disease, the five-year survival decreases 40% compared to patients without nodal metastases. With the approval of interferon alfa-2b as the first effective adjuvant therapy for the high risk for r...

the effect of creative writing instruction on lexical density of advanced efl learners writing

چکیده ندارد.

Treatment of advanced malignant lymphomas with bleomycin.

Bieomycin, a new antitumor agent rea fourth relapsed after 13 mo. Myeloported to lack myeiotoxicity, was adtoxicity was conspicuously uncommon ministered to 43 patients with dissemiand serious pulmonary toxicity ocnated refractory lymphomas. Either a curred in only one patient. Bleomycin weekly or daily regimen was used has significant activity in the malignant and in order to minimize the poss...

Management of dyspnea in patients with far-advanced lung disease.

Dyspnea is a common problem among patients with interstitial fibrosis, lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease. The slow but steady progression of such diseases, often punctuated by acute exacerbations or secondary illnesses, can lead to decision-making dilemmas among patients and their caregivers, such as when to accept mechanical ventilation, when to forgoe agg...

New therapeutical approaches for the treatment of malignant Melanoma